Ingelheim, Germany Saturday, February 15, 2025, 12:00 Hrs [IST] ...

Roche and Boehringer Ingelheim have both formed partnerships with tech companies this week to develop and deploy wearable biosensor technology for use in clinical trials and patient monitoring ...

Armed with results from a phase 2 trial, Boehringer Ingelheim has said it will take its obesity drug candidate survodutide into a phase 3 programme later this year. The glucagon/GLP-1 receptor ...

Cat, or Caterpillar, is a US-based construction machinery manufacturing company. The company licensed its brand to UK-based Bullitt Mobile back in 2013, which has since been producing Cat-branded ...

Net interest income was 14% higher YoY, at ₹587.7 crore, due to steady loan growth & higher interest margins than Q3 FY24 levels of ₹516 crore.

Please click on a company to view the full profile: ...